How Abbott’s Newest Indication Is Reshaping Heart Failure Management

[cafead]

via Abbott Laboratories’ CardioMems sensor is changing the way pulmonary arterial pressures are monitored and managed in heart failure patients. And now, with a recent nod from FDA, the CardioMems HF System has an indication that will allow it to reach an additional 1.2 million people living with heart failure.

article source